ConductScience.org, home

Paper25136604

Disruption of HPV16-E7 by CRISPR/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells.

Hu Z and 13 others. Biomed Res Int, 2014. Cited by 167 papers, by iCite.

Cite this record

ConductScience Library. Disruption of HPV16-E7 by CRISPR/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells. Papers, record 25136604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25136604

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Disruption of HPV16-E7 by CRISPR/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells.
PubMed
Journal
Biomed Res Int
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
167
iCite
Relative citation ratio, by iCite
4.42
iCite
Revised in PubMed
2024-01-04
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hu ZZheng
2Yu LLan
3Zhu DDa
4Ding WWencheng
5Wang XXiaoli
6Zhang CChanglin
7Wang LLiming
8Jiang XXiaohui
9Shen HHui
10He DDan
11Li KKezhen
12Xi LLing
13Ma DDing
14Wang HHui

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CRISPR-Cas SystemsMajor topic
Cell ProliferationMajor topic
Papillomavirus E7 ProteinsMajor topic
Uterine Cervical NeoplasmsMajor topic
Apoptosis
Female
HEK293 Cells
Human papillomavirus 16
Humans

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT03057912A Safety and Efficacy Study of TALEN and CRISPR/Cas9 in the Treatment of HPV-related Cervical Intraepithelial NeoplasiaⅠBackground

Source ClinicalTrials.gov

Download CSV of trials

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120331326Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.J Manag Care Pharm2010https://conductscience.org/library/papers/20331326PubMed
219861444Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications.Clin Cancer Res2009https://conductscience.org/library/papers/19861444PubMed
320680825The generation of zinc finger proteins by modular assembly.Methods Mol Biol2010https://conductscience.org/library/papers/20680825PubMed
417379808CRISPR provides acquired resistance against viruses in prokaryotes.Science2007https://conductscience.org/library/papers/17379808PubMed
523979578Targeted heritable mutation and gene conversion by Cas9-CRISPR in Caenorhabditis elegans.Genetics2013https://conductscience.org/library/papers/23979578PubMed
619470664Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly.Genome Res2009https://conductscience.org/library/papers/19470664PubMed
712083799Induction of senescence-like state and suppression of telomerase activity through inhibition of HPV E6/E7 gene expression in cells immortalized by HPV16 DNA.Exp Cell Res2002https://conductscience.org/library/papers/12083799PubMed
812044010Papillomaviruses and cancer: from basic studies to clinical application.Nat Rev Cancer2002https://conductscience.org/library/papers/12044010PubMed
923287722RNA-guided human genome engineering via Cas9.Science2013https://conductscience.org/library/papers/23287722PubMed
1023992846Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.Cell2013https://conductscience.org/library/papers/23992846PubMed
1123360964Efficient genome editing in zebrafish using a CRISPR-Cas system.Nat Biotechnol2013https://conductscience.org/library/papers/23360964PubMed
1212897142Pathways of DNA double-strand break repair during the mammalian cell cycle.Mol Cell Biol2003https://conductscience.org/library/papers/12897142PubMed
1319158789The promises and pitfalls of RNA-interference-based therapeutics.Nature2009https://conductscience.org/library/papers/19158789PubMed
1423471067RNA guides genome engineering.Nat Biotechnol2013https://conductscience.org/library/papers/23471067PubMed
1523792628High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells.Nat Biotechnol2013https://conductscience.org/library/papers/23792628PubMed
1618755502Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer.Gynecol Oncol2008https://conductscience.org/library/papers/18755502PubMed
1712727893Non-homologous end joining as an important mutagenic process in cell cycle-arrested cells.EMBO J2003https://conductscience.org/library/papers/12727893PubMed
1812208848Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation.Genes Dev2002https://conductscience.org/library/papers/12208848PubMed
1912556961Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis.Br J Cancer2003https://conductscience.org/library/papers/12556961PubMed

Download CSV of references

Cited by121

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 167 citations.

PMIDTitleJournalYearIn PapersSource
42819744Advances in immunotherapy for HPV-associated malignancies: emerging strategies and clinical progress.Front Immunol2026https://conductscience.org/library/papers/42819744PubMed
42554845CRISPR/Cas system as a novel therapeutic strategy to combat multi-drug-resistant bacteria.Arch Microbiol2026https://conductscience.org/library/papers/42554845PubMed
42493737Advancing Antiviral Design: Integrating Natural Products, Computation and Targeted Delivery.Chem Biol Drug Des2026https://conductscience.org/library/papers/42493737PubMed
42328613Role of CRISPR-Cas system as a new approach in fighting the antimicrobial resistance of bacterial and viral pathogens.Infect Dis Immun2025https://conductscience.org/library/papers/42328613PubMed
42277467Innovative strategies to overcome cancer drug resistance: from nanodelivery systems to targeted therapeutics.Discov Oncol2026https://conductscience.org/library/papers/42277467PubMed
41596696In Silico Design and Characterization of a Rationally Engineered Cas12j2 Gene Editing System for the Treatment of HPV-Associated Cancers.Int J Mol Sci2026https://conductscience.org/library/papers/41596696PubMed
41476860Therapeutic applications of CRISPR-Cas9 gene editing.Front Genome Ed2025https://conductscience.org/library/papers/41476860PubMed
41420181HPV-driven inflammatory pathways in ovarian carcinogenesis: molecular mechanisms and emerging therapeutic interventions.J Ovarian Res2025https://conductscience.org/library/papers/41420181PubMed
41304764Targeted Drug Delivery Strategies in Overcoming Antimicrobial Resistance: Advances and Future Directions.Pharmaceutics2025https://conductscience.org/library/papers/41304764PubMed
41284414CRISPR Technology: Transforming the Future of Medicine and Diagnostics.Biochemistry2025https://conductscience.org/library/papers/41284414PubMed
41171314CRISPR-based gene therapy for huntington's disease: current advances and future prospects.Neurogenetics2025https://conductscience.org/library/papers/41171314PubMed
41020881Emerging Therapeutic Strategies for HPV-Related Cancers: From Gene Editing to Precision Oncology.Curr Issues Mol Biol2025https://conductscience.org/library/papers/41020881PubMed
40943604Disruption of Human Papillomavirus 16 E6/E7 Genes Using All-in-One Adenovirus Vectors Expressing Eight Double-Nicking Guide RNAs.Int J Mol Sci2025https://conductscience.org/library/papers/40943604PubMed
40831701Towards the elimination of infectious HPV: exploiting CRISPR/Cas innovations.Front Cell Infect Microbiol2025https://conductscience.org/library/papers/40831701PubMed
40400023HPV-driven cancers: a looming threat and the potential of CRISPR/Cas9 for targeted therapy.Virol J2025https://conductscience.org/library/papers/40400023PubMed
40095096Revealing the viral culprits: the hidden role of the oral virome in head and neck cancers.Arch Microbiol2025https://conductscience.org/library/papers/40095096PubMed
39834176Research Status of Clustered Regulary Interspaced Short Palindromic Repeats Technology in the Treatment of Human Papillomavirus (HPV) Infection Related Diseases.Cancer Control2025https://conductscience.org/library/papers/39834176PubMed
39769084Expanding Horizons of CRISPR/Cas Technology: Clinical Advancements, Therapeutic Applications, and Challenges in Gene Therapy.Int J Mol Sci2024https://conductscience.org/library/papers/39769084PubMed
39619730CRISPR-Cas Systems in the Fight Against Antimicrobial Resistance: Current Status, Potentials, and Future Directions.Infect Drug Resist2024https://conductscience.org/library/papers/39619730PubMed
39524822Emerging Gene-editing nano-therapeutics for Cancer.Heliyon2024https://conductscience.org/library/papers/39524822PubMed

See all 121 cited byDownload CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25136604

GET https://conductscience.org/api/papers/v1/25136604/cited_by?page=2